SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SCIO Scios Inc. -- Ignore unavailable to you. Want to Upgrade?


To: JFitnich who wrote (1454)2/7/2003 9:29:37 AM
From: Biomaven  Respond to of 1477
 
Here's their release:

Scios Comments on Discussions Regarding Potential Strategic Transactions

SUNNYVALE, Calif., Feb. 7 /PRNewswire-FirstCall/ --
Scios Inc. (NASDAQ:SCIO) stated today that it is engaged in discussions with
a number of life sciences companies concerning potential strategic
transactions. The transactions being discussed include partnering
arrangements for the Scios p38 MAP kinase inhibitor program and mergers.
Scios stated that no agreement has been reached with respect to any of these
potential strategic transactions. While Scios may enter into a strategic
transaction, no assurance can be given that it will do so.


Best case is a bidding war. <g>

Peter